Literature DB >> 19465770

A charged residue at the subunit interface of PCNA promotes trimer formation by destabilizing alternate subunit interactions.

Bret D Freudenthal1, Lokesh Gakhar, S Ramaswamy, M Todd Washington.   

Abstract

Eukaryotic proliferating cell nuclear antigen (PCNA) is an essential replication accessory factor that interacts with a variety of proteins involved in DNA replication and repair. Each monomer of PCNA has an N-terminal domain A and a C-terminal domain B. In the structure of the wild-type PCNA protein, domain A of one monomer interacts with domain B of a neighboring monomer to form a ring-shaped trimer. Glu113 is a conserved residue at the subunit interface in domain A. Two distinct X-ray crystal structures have been determined of a mutant form of PCNA with a substitution at this position (E113G) that has previously been studied because of its effect on translesion synthesis. The first structure was the expected ring-shaped trimer. The second structure was an unanticipated nontrimeric form of the protein. In this nontrimeric form, domain A of one PCNA monomer interacts with domain A of a neighboring monomer, while domain B of this monomer interacts with domain B of a different neighboring monomer. The B-B interface is stabilized by an antiparallel beta-sheet and appears to be structurally similar to the A-B interface observed in the trimeric form of PCNA. The A-A interface, in contrast, is primarily stabilized by hydrophobic interactions. Because the E113G substitution is located on this hydrophobic surface, the A-A interface should be less favorable in the case of the wild-type protein. This suggests that the side chain of Glu113 promotes trimer formation by destabilizing these possible alternate subunit interactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465770      PMCID: PMC2685733          DOI: 10.1107/S0907444909011329

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  21 in total

1.  PHENIX: building new software for automated crystallographic structure determination.

Authors:  Paul D Adams; Ralf W Grosse-Kunstleve; Li Wei Hung; Thomas R Ioerger; Airlie J McCoy; Nigel W Moriarty; Randy J Read; James C Sacchettini; Nicholas K Sauter; Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-10-21

2.  Intermolecular ion pairs maintain the toroidal structure of Pyrococcus furiosus PCNA.

Authors:  Shigeki Matsumiya; Sonoko Ishino; Yoshizumi Ishino; Kosuke Morikawa
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

Review 3.  The PCNA-RFC families of DNA clamps and clamp loaders.

Authors:  Jerzy Majka; Peter M J Burgers
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2004

Review 4.  PCNA, the maestro of the replication fork.

Authors:  George-Lucian Moldovan; Boris Pfander; Stefan Jentsch
Journal:  Cell       Date:  2007-05-18       Impact factor: 41.582

Review 5.  PCNA binding proteins.

Authors:  T Tsurimoto
Journal:  Front Biosci       Date:  1999-12-01

6.  A novel function of DNA polymerase zeta regulated by PCNA.

Authors:  Matthew R Northam; Parie Garg; Dmitri M Baitin; Peter M J Burgers; Polina V Shcherbakova
Journal:  EMBO J       Date:  2006-09-07       Impact factor: 11.598

7.  Expression and physicochemical characterization of human proliferating cell nuclear antigen.

Authors:  P Zhang; S J Zhang; Z Zhang; J F Woessner; M Y Lee
Journal:  Biochemistry       Date:  1995-08-29       Impact factor: 3.162

Review 8.  Proliferating cell nuclear antigen (PCNA): a dancer with many partners.

Authors:  Giovanni Maga; Ulrich Hubscher
Journal:  J Cell Sci       Date:  2003-08-01       Impact factor: 5.285

Review 9.  Proliferating cell nuclear antigen: a proteomics view.

Authors:  S N Naryzhny
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

Review 10.  Clamping down on clamps and clamp loaders--the eukaryotic replication factor C.

Authors:  R Mossi; U Hübscher
Journal:  Eur J Biochem       Date:  1998-06-01
View more
  8 in total

1.  Expression, purification and preliminary X-ray analysis of proliferating cell nuclear antigen from the archaeon Thermococcus thioreducens.

Authors:  Miranda L Byrne-Steele; Joseph D Ng
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-08-22

2.  PCNA and Msh2-Msh6 activate an Mlh1-Pms1 endonuclease pathway required for Exo1-independent mismatch repair.

Authors:  Eva M Goellner; Catherine E Smith; Christopher S Campbell; Hans Hombauer; Arshad Desai; Christopher D Putnam; Richard D Kolodner
Journal:  Mol Cell       Date:  2014-06-26       Impact factor: 17.970

Review 3.  The Many Roles of PCNA in Eukaryotic DNA Replication.

Authors:  E M Boehm; M S Gildenberg; M T Washington
Journal:  Enzymes       Date:  2016-04-19

4.  Nicotine mediates hypochlorous acid-induced nuclear protein damage in mammalian cells.

Authors:  Samir A Salama; Hany H Arab; Hany A Omar; Ibrahim A Maghrabi; Robert M Snapka
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

5.  The non-canonical protein binding site at the monomer-monomer interface of yeast proliferating cell nuclear antigen (PCNA) regulates the Rev1-PCNA interaction and Polζ/Rev1-dependent translesion DNA synthesis.

Authors:  Neeru M Sharma; Olga V Kochenova; Polina V Shcherbakova
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

Review 6.  PCNA structure and function: insights from structures of PCNA complexes and post-translationally modified PCNA.

Authors:  Lynne M Dieckman; Bret D Freudenthal; M Todd Washington
Journal:  Subcell Biochem       Date:  2012

7.  PCNA trimer instability inhibits translesion synthesis by DNA polymerase η and by DNA polymerase δ.

Authors:  Lynne M Dieckman; M Todd Washington
Journal:  DNA Repair (Amst)       Date:  2013-03-15

8.  Identification of New Mutations at the PCNA Subunit Interface that Block Translesion Synthesis.

Authors:  Christine M Kondratick; Elizabeth M Boehm; Lynne M Dieckman; Kyle T Powers; Julio C Sanchez; Samuel R Mueting; M Todd Washington
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.